Please login to the form below

Not currently logged in

follicular lymphoma

This page shows the latest follicular lymphoma news and features for those working in and with pharma, biotech and healthcare.

BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform

BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform

Tecartus is used to treat adults with mantle cell lymphoma, and is indicated for patients whose cancer has returned after two or more previous treatments, including a BTK inhibitor. ... Meanwhile, Yescarta is used to treat follicular lymphoma and is also

Latest news

More from news
Approximately 3 fully matching, plus 60 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...